BamSEC and AlphaSense Join Forces
Learn More

Trevi Therapeutics Inc. – Articles of Incorporation

NASDAQ: TRVI    
Share price (8/6/26): $18.50    
Market cap (8/6/26): $2.627 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 3 pages Certificate of Amendment to the Restated Certificate of Incorporation of Trevi Therapeutics, Inc. (Pursuant to Section 242 of the General Corporation Law of the State of Delaware) [Remainder of Page Intentionally Left Blank]
12/34/56
EX-3.1
from 10-Q 13 pages Restated Certificate of Incorporation of Trevi Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment to the Restated Certificate of Incorporation of Trevi Therapeutics, Inc. (Pursuant to Section 242 of the General Corporation Law of the State of Delaware) [Remainder of Page Intentionally Left Blank]
12/34/56
EX-3
from 8-K 18 pages Amended and Restated Bylaws of Trevi Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 29 pages Stockholders
12/34/56
EX-3.1
from 8-K 10 pages Restated Certificate of Incorporation of Trevi Therapeutics, Inc
12/34/56
EX-3.3
from S-1/A 4 pages Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Trevi Therapeutics, Inc
12/34/56
EX-3.5
from S-1 29 pages Stockholders
12/34/56
EX-3.4
from S-1 10 pages Restated Certificate of Incorporation of Trevi Therapeutics, Inc
12/34/56
EX-3.2
from S-1 16 pages Stockholders
12/34/56
EX-3.1
from S-1 40 pages Trevi Therapeutics, Inc. Third Amended and Restated Certificate of Incorporation Third Amended and Restated Certificate of Incorporation of Trevi Therapeutics, Inc
12/34/56
EX-3.2
from DRS 16 pages Stockholders
12/34/56
EX-3.1
from DRS 40 pages Trevi Therapeutics, Inc. Third Amended and Restated Certificate of Incorporation Third Amended and Restated Certificate of Incorporation of Trevi Therapeutics, Inc
12/34/56